Research Article

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study

Table 1

Baseline clinicopathological characteristics of all patients and those in the training and validation cohorts.

VariablesAll cohort (n = 19617)Training cohort (n = 13732)Validation cohort (n = 5885)

Age0.026
<604203(21.4)4958 (36.1)1302 (22.1)
60–697054(36.0)2096 (35.6)
70–796588(33.6)4619 (33.6)1969 (33.5)
>801772(9.0)1254 (9.1)518 (8.8)

Race0.019
White16312(83.2)11445 (83.3)4867 (82.7)
Black1814(9.2)1262 (9.2)552 (9.4)
Others1491(7.6)1025 (7.5)466 (7.9)

Sex0.013
Male9807(50.0)6839 (49.8)2968 (50.4)
Female9810(50.0)6893 (50.2)2917 (49.6)

Stage0.017
I11543(58.8)8047 (58.6)3496 (59.4)
II4572(23.3)3226 (23.5)1346 (22.9)
III3502(17.9)2459 (17.9)1043 (17.7)

Histology0.009
Adenocarcinoma12278(62.6)8579 (62.5)3702 (62.9)
Squamous7336(37.4)5153 (37.5)2183 (37.1)

Surgery0.014
Complete resection1092(5.6)778 (5.7)314 (5.3)
Partial resection18525(94.4)12954 (94.3)5571 (94.7)
Positive nodes0.005
Yes4812(24.5)3360 (24.5)1452 (24.7)
No14805(75.5)10372 (75.5)4433 (75.3)